BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18086565)

  • 1. Proteomic identification of ZO-1/2 as a novel scaffold for Src/Csk regulatory circuit.
    Saito K; Enya K; Oneyama C; Hikita T; Okada M
    Biochem Biophys Res Commun; 2008 Feb; 366(4):969-75. PubMed ID: 18086565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic, functional and motif-based analysis of C-terminal Src kinase-interacting proteins.
    Yang G; Li Q; Ren S; Lu X; Fang L; Zhou W; Zhang F; Xu F; Zhang Z; Zeng R; Lottspeich F; Chen Z
    Proteomics; 2009 Nov; 9(21):4944-61. PubMed ID: 19743411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
    Mikkola ET; Gahmberg CG
    J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src.
    Oneyama C; Hikita T; Enya K; Dobenecker MW; Saito K; Nada S; Tarakhovsky A; Okada M
    Mol Cell; 2008 May; 30(4):426-36. PubMed ID: 18498747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
    Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
    Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase.
    Lin X; Wang Y; Ahmadibeni Y; Parang K; Sun G
    J Mol Biol; 2006 Apr; 357(4):1263-73. PubMed ID: 16483606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity.
    Solheim SA; Petsalaki E; Stokka AJ; Russell RB; Taskén K; Berge T
    FEBS J; 2008 Oct; 275(19):4863-74. PubMed ID: 18721137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coupled motions in the SH2 and kinase domains of Csk control Src phosphorylation.
    Wong L; Lieser SA; Miyashita O; Miller M; Tasken K; Onuchic JN; Adams JA; Woods VL; Jennings PA
    J Mol Biol; 2005 Aug; 351(1):131-43. PubMed ID: 16002086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk.
    Lin X; Ayrapetov MK; Lee S; Parang K; Sun G
    Biochemistry; 2005 Feb; 44(5):1561-7. PubMed ID: 15683240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases.
    Kawabuchi M; Satomi Y; Takao T; Shimonishi Y; Nada S; Nagai K; Tarakhovsky A; Okada M
    Nature; 2000 Apr; 404(6781):999-1003. PubMed ID: 10801129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ups and downs of SRC regulation: tumor suppression by Cbp.
    Resh MD
    Cancer Cell; 2008 Jun; 13(6):469-71. PubMed ID: 18538730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of major tyrosine-phosphorylated proteins in Csk-deficient cells.
    Nada S; Okada M; Aizawa S; Nakagawa H
    Oncogene; 1994 Dec; 9(12):3571-8. PubMed ID: 7526315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmembrane phosphoprotein Cbp senses cell adhesion signaling mediated by Src family kinase in lipid rafts.
    Shima T; Nada S; Okada M
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14897-902. PubMed ID: 14645715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress activates both Src-kinases and their negative regulator Csk and induces phosphorylation of two targeting proteins for Csk: caveolin-1 and paxillin.
    Cao H; Sanguinetti AR; Mastick CC
    Exp Cell Res; 2004 Mar; 294(1):159-71. PubMed ID: 14980511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crk adaptor protein-induced phosphorylation of Gab1 on tyrosine 307 via Src is important for organization of focal adhesions and enhanced cell migration.
    Watanabe T; Tsuda M; Makino Y; Konstantinou T; Nishihara H; Majima T; Minami A; Feller SM; Tanaka S
    Cell Res; 2009 May; 19(5):638-50. PubMed ID: 19350053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.